All Activity

We don't believe in pushing clients into quick decisions. Our Escorts Service in Connaught Place gives you time to think, ask questions, and feel comfortable before booking. We're not here to pressure anyone. We simply introduce you to wonderful companions who are genuinely good at making people feel valued. That's what keeps our clients happy and coming back.

It is truly a well-researched content and excellent wording. I got so engaged in this material that I couldn’t wait reading. I am impressed with your work and skill. Thanks. 성인피시

Very nice article, I enjoyed reading your post, very nice share, I want to twit this to my followers. Thanks!. 성인 피시방 매매

This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free. 성인 피시방 단속

Geometry Dash employs a minimalist yet striking graphic style, featuring vibrant neon colors, glowing effects, and smooth motion. Each level boasts a unique visual theme, ensuring a fresh experience as players embark on the next challenge.

“Given the evolving policy environment around us, what does this mean for our state’s cannabis policy framework?” By Claire Fiddian-Green, Richard M. Fairbanks Foundation via Indiana Capital Chronicle Indiana’s cannabis policy has recently become a subject of increasing scrutiny. While our state’s cannabis laws are among the most restrictive in the nation, three of our four neighboring states have legalized adult-use cannabis, and the federal government has indicated interest in relaxing federal cannabis laws. This context means that, even with Indiana’s restrictive policies, cannabis is accessible to most Hoosiers. According to two new reports from RAND, commissioned by the Richard M. Fairbanks Foundation, 44 percent of Indiana residents live within 50 miles of a licensed dispensary in another state, and 96 percent live within 100 miles. Additionally, another key reality requires us to carefully consider Indiana’s current policy framework: intoxicating hemp products, which can contain the same psychoactive compound as marijuana, are widely available at gas stations, convenience stores and grocery stores across the state—with limited oversight. The Hoosier state does not exist in a vacuum: our health and economic outcomes are already influenced by the regulatory and enforcement decisions made by the federal government and neighboring states, and that will only continue. Evaluating the options and costs For Indiana, this raises a critical question. Given the evolving policy environment around us, what does this mean for our state’s cannabis policy framework? As Indiana considers this, we can learn from what other U.S. states—and even other countries—have done well and where they’ve run into pitfalls. Whether current policies remain intact or change, Indiana leaders should seize the chance to carefully study data and assess policy options, as the consequences of any decision will likely be significant. Rather than recommending a particular policy design, the RAND reports describe various approaches to cannabis regulation and the potential tradeoffs of different choices. For example, Indiana could consider maintaining the status quo of prohibition, reducing criminal penalties for possession, legalizing medical cannabis or legalizing a recreational adult-use market. RAND further describes 14 policy considerations that are relevant to establishing legal markets—each of which could influence the state’s public health and economic outcomes in various ways. The fact is, cannabis use in Indiana has more than doubled over the past decade, with growth especially pronounced among adults 26 and over. In total, RAND estimates the 1.3 million Hoosiers who used cannabis in 2024 spent approximately $1.8 billion on marijuana products. At the same time, Indiana recorded over 13,000 cannabis-related arrests in 2024, with over 90 percent for possession and more than 75 percent in connection with non-cannabis charges. The state spends an estimated $10 million to $20 million annually on cannabis law enforcement. While changes to cannabis policy, including legalization, could reduce these costs, they would not eliminate them entirely. After significant start-up costs, the state’s cost to regulate and oversee an adult-use market could be in the low tens of millions of dollars annually, potentially exceeding any cost savings from reduced criminal justice expenditures. Legalizing adult-use recreational cannabis is estimated to generate about $180 million in annual state revenue, roughly 1 percent of the state’s general fund. Notably, this estimate is far lower than some have suggested. For a point of comparison, in 2025, cigarette and alcohol taxes brought in a combined $385 million, according to the Indiana Department of Revenue. As the policy landscape evolves, a range of factors must be considered, including industry trends and pressures of the legal market, the persistence of illegal markets, the rise of intoxicating hemp products, and the potential for national legalization, all of which make conversations about Indiana’s cannabis policy more complex and nuanced. As Indiana considers the optimal framework for cannabis regulation, it is critical our state takes a thoughtful, data-informed approach. The decisions leaders make today will carry ripple effects for Hoosiers—and other states across the U.S. Claire Fiddian-Green is president and CEO of the Richard M. Fairbanks Foundation. This piece was first published by Indiana Capital Chronicle. The post As Surrounding States Legalize Marijuana, Indiana Officials Need A Data-Informed Approach To Reforming Laws (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A powerful congressional committee is allowing a psychedelics-focused amendment to a major military bill to proceed to a floor vote in the House of Representatives—but it is also blocking other cannabis- and drug-related proposals from advancing. The House Rules Committee on Monday considered the amendments to the National Defense Authorization Act (NDAA) for Fiscal Year 2027, allowing one that would extend a psychedelics research effort at the Department of Defense (DOD) for an additional six years to move forward. Sponsored by Reps. Morgan Luttrell (R-TX), Jack Bergman (R-MI), Derrick Van Orden (R-WI), Mike Ezell (R-MS), Troy Carter (D-LA) and Morgan McGarvey (D-KY), Lou Correa (DCA), Seth Moulton (D-MA), Sarah Elfreth (D MD) and Michael Rulli(R-OH), the amendment seeks to include language in the bill expanding DOD studies on psychedelics that were first authorized under the earlier 2024 NDAA. That program, signed into law by then-President Joe Biden, directed DOD to establish a process by which active duty service members with post-traumatic stress disorder (PTSD) or traumatic brain injury could participate in clinical trials involving psilocybin, MDMA, ibogaine, 5-MeO-DMT and “qualified plant-based alternative therapies.” As enacted, it only required the secretary of defense to issue updated reports on progress within one year of the law passing and then annually for three years after that. The new amendment would replace “three years” in the law with “nine years.” It also specifies that DOD would have to “extend the performance of research conducted using funding awarded under this section to September 30, 2033.” The previously enacted legislation, which was also championed by Luttrell, set aside $10 million to fund the military psychedelic studies. Earlier this month, the House Armed Services Committee approved its version of NDAA and an attached report that calls on military officials to pay greater attention to potential “access pathways” to psychedelic therapies for servicemembers. Citing a psychedelics executive order signed by President Donald Trump in April, the panel urged DOD leaders to “remain informed of lawful research and access pathways relevant to post-traumatic stress disorder and other serious mental health conditions affecting servicemembers during post-deployment and transition periods, and members of the Reserve Components and National Guard who also serve as first responders.” That includes studies on “psilocybin-containing investigational products, including naturally derived whole-mushroom formulations administered in structured therapeutic settings,” the report that the panel approved to be attached to NDAA says. The panel is directing the secretary of defense to issue a report by February 1, 2027 that assesses data on such trials, along with an assessment of “legal and regulatory requirements for expanded access,” including under Trump’s psychedelics executive order as well as a Right to Try law the president signed during his first term in office. The secretary’s report would also need to include a “proposed timeline for potential pilot activities or expanded clinical research beginning in fiscal year 2027, and for any broader implementation thereafter.” Lawmakers also used last year’s NDAA to push DOD for a “progress report” on the ongoing psychedelic therapy clinical trials. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Another proposed amendment to the current NDAA from Reps. Dave Joyce (R-OH) and Dina Titus (D-NV), would have expanded waivers for military recruits who’ve tested positive for marijuana—but the Rules Committee is not allowing it to advance. The amendment acknowledges that the Army and Navy have already “taken positive steps in their work to design and implement a waiver system that permits potential enlistees into the Armed Forces to reapply for enlistment following a positive toxicology test for tetrahydrocannabinol.” It calls on the Air Force, Space Force and Marine Corps to follow through, especially “given the ongoing recruitment and retention challenges undermining the Armed Forces readiness goals.” A similar measure filed by Joyce and Titus, who are co-chairs of the Congressional Cannabis Caucus, was passed by the House of Representatives last year but was not enacted into law. The current measure would have required those military branches to “develop and implement their own permanent waiver system commensurate with the process employed by the Army and Navy.” It says that the secretary of defense “shall develop a program through which to provide waivers for potential enlistees into the Armed Forces who were not permitted to enlist following a positive toxicology test for tetrahydrocannabinol so that such potential enlistees are permitted to reapply for enlistment.” Further, the Department of Defense would have been required to “assess the feasibility of contacting” prospective enlistees who were previously rejected over cannabis and, “to the extent feasible, develop a plan to contact such potential enlistees.” Within 180 days of enactment, the defense secretary would have needed to submit a report to the congressional committees of jurisdiction with a “plan to create, disseminate, and use a clear definition that highlights that all waivered recruits are qualified and eligible to enlist in the Armed Forces, even if they do not meet every enlistment standard, and that existing standards of enlistment allow for waivers.” In April, the Army enacted a new policy making it so recruits will no longer need to obtain a waiver to enlist if they have a single conviction for possessing marijuana or drug paraphernalia on their records. Another drug policy amendment to NDAA that was blocked, from Reps. Madeleine Dean (D-PA) and Nancy Mace (R-SC), would have allowed doctors to administer Schedule I drugs such as certain psychedelics to patients with life-threatening conditions by expanding on the country’s “right to try” law. The policy creates an exception within the Controlled Substances Act (CSA) that gives qualified patients access to potential therapies that haven’t yet been approved by the Food and Drug Administration (FDA). The Dean-Mace proposal is similar to a standalone bill the bipartisan duo filed in Congress late last year. The lawmakers noted when filing the earlier bill that the Food and Drug Administration (FDA) has designated two psychedelics, MDMA and psilocybin, as breakthrough therapies for the treatment of serious mental health conditions. Yet the Drug Enforcement Administration (DEA) currently has no pathway to authorize physicians to administer the drugs despite the broader right to try policy, they said. To address that, the new legislation would amend current statute to allow DEA to register and authorize doctors to administer the novel therapeutics. In 2024, the House passed a version of NDAA that would have prevented drug testing for marijuana as a condition of enlistment in the military or for commission as an officer. But it was not included in the final version that was signed into law following bicameral negotiations with the Senate. Lawmakers have also previously considered amendments to address restrictive military policies prohibiting service members from using hemp products. Last month, for example, the Army published a post reminding soldiers of its “zero-tolerance” policy for all forms of cannabis and its derivatives—including hair care products and lotions made from hemp. Last year, a memo to Air Force personnel in Massachusetts warned that not only marijuana but also hemp-derived cannabinoids, including CBD and delta-8 THC, are prohibited on military bases and related properties. In 2022, the Air Force expressed concern that even using CBD-infused hand sanitizer or hemp granola could inadvertently compromise “military readiness.” After its initial 2019 announcement, DOD more broadly reaffirmed that CBD is off limits to service members in notices published in 2020. The Navy, for its part, issued an initial notice in 2018 informing ranks that they’re barred from using CBD and hemp products no matter their legality. Then in 2020 it released an update explaining why it enacted the rule change. The Coast Guard said that sailors can’t use marijuana or visit state-legal dispensaries. Separately, a general in 2022 said that the Air Force and Space Force were reviewing marijuana policies and considering a “common sense” change that could give potential recruits a pass if they test positive for cannabis. Image element courtesy of Kristie Gianopulos. The post Congressional Committee Allows Military Psychedelics Amendment To Advance But Blocks Marijuana Testing Proposal For Recruits appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A new poll of marijuana consumers shows they are overwhelmingly more likely to want to dine at restaurants that offer cannabis-derived THC drinks as an alternative to alcohol. The new survey, conducted by cannabis telehealth platform NuggMD, found that 54 percent of people who use marijuana and live in state-legal markets would be much more likely to visit a local restaurant that offered THC beverages. Another 23 percent said they are somewhat more likely to dine there, while 21 percent said it would have no effect on their decision and 3 percent said they would be less likely to become a patron. “While most cannabis consumers prefer to use regular flower in the comfort of their own home, our polling does reflect a clear openness to social consumption,” Andrew Graham, head of communications for NuggMD, told Marijuana Moment. “For example, a separate poll from last year found most cannabis consumers say they have either high or moderate interest in dispensaries that double as cafes, social clubs, or wellness hubs.” The poll comes shortly after the Texas steakhouse chain Logan’s Roadhouse announced it would begin testing three THC-infused cocktails at 14 of its locations. “Beverage strikes me as the most appropriate ingestion format for social consumption, and that’s probably why both independent restaurants and chains like Logan’s Roadhouse are trying it out,” Graham said. “It’s clearly popular with consumers and the margins are probably on par with liquor.” “The problem is the looming re-criminalization of hemp THC that’s currently set to go into effect in November, which would pull these products off of shelves and menus,” he said, referring to a new law to change the federal definition of legal hemp products. “Allowing that ban to go into effect would be a mistake that harms both businesses and consumers.” Q: “A restaurant chain recently announced it will begin selling non-alcoholic, hemp THC beverages to adults at select locations. If a restaurant near you offered THC beverages, how would it affect your likelihood of visiting?” n: % Much more likely to visit 470 53.8% Somewhat more likely to visit 199 22.8% No effect 182 20.8% Less likely to visit 22 2.5% The NuggMD poll involved interviews with 873 cannabis consumers who live in state-legal markets from June 18-21 and has a margin of error of 3.32 percentage points. The National Restaurant Association, which represents the industry, recently sent a letter urging congressional leaders to delay the federal recriminalization of hemp THC beverages that is scheduled to take effect later this year and replace it with a regulatory framework that “ensures consumer safety while meeting growing market demand” for the products as an alternative to alcohol. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, he signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. As Marijuana Moment reported this month, a Republican congresswoman is circulating draft legislation that would keep hemp THC beverages legal under federal law, creating a carve-out from the broad recriminalization of products derived from the crop that is set to take effect later this year. The Hemp-Derived Beverage Regulatory Clarity Act from Rep. Beth Van Duyne (R-TX), in its current form, would allow adults over 21 to purchase and consume hemp THC drinks with up to 5 milligrams of delta-9 THC per serving. It would also impose a federal tax of 10 cents per milligram of any hemp-derived cannabinoid contained within such beverages. The circulation of the new draft legislation and the restaurant group’s push comes as the White House is making it clear that Trump wants Congress to take action to amend the law that threatens to federally recriminalize hemp-derived products. In a letter to House Speaker Mike Johnson (R-LA) this month, White House Office of Management and Budget (OMB) Director Russell Vought said the administration wants lawmakers to “ensure the fair treatment of hemp products”—specifically citing legislation that would keep many hemp products legal that are currently set to be recriminalized this year, add labeling requirements and institute new taxes on sales, among other regulatory reforms. The administration “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” OMB separately said this month, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” The call to avert a broad prohibition on hemp CBD products was included in a statement of administration policy about an annual agriculture spending bill that passed the House of Representatives. Several lawmakers had filed amendments to that legislation to keep hemp products legal, but each was either blocked by the House Rules Committee from advancing to a floor vote or withdrawn by its sponsor. “The Administration supports advancement of this legislation, but looks forward to addressing its concerns prior to enactment,” OMB said in its statement of administration policy. “The Administration looks forward to working with the Congress to provide more input as the bill’s legislative process unfolds.” In April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post on the same day his administration announced it is moving forward with rescheduling marijuana. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” He also referenced a new initiative the administration launched in April to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” It’s not clear how far Trump wants to scale back the scope of the scheduled federal restrictions on hemp products and what kinds of revised THC rules and limitations he would prefer to sign into law. Separately, White House officials recently provided a congressman’s office with feedback on hemp regulatory legislation. In April, Vince Haley, director of the White House Domestic Policy Council and James Braid, assistant to the president for legislative affairs, sent hemp policy suggestions to Rep. Andy Barr (R-KY). “We appreciate your work to advance the policy of” an executive order Trump signed in December that included provisions seeking to protect Americans’ access to CBD products, the staffers wrote in a letter to the congressman. “We are transmitting for your consideration draft legislative text and comments to address the statutory definition of final hemp-derived cannabinoid products in order to allow Americans to benefit from access to appropriate full-spectrum CBD products while preserving the Congress’s intent to restrict the sale of products that pose serious health risks,” the White House officials said, according to a social media post containing a screenshot of the letter. “We are available for discussion and further technical assistance.” A U.S. Department of Agriculture report published in April shows that farmers in the U.S. grew three-quarters of a billion dollars worth of hemp crops in 2025—a 64 percent increase from the prior year. A previous NuggMD poll found that cannabis consumers are more likely to shop at Target following the major retailer’s decision to start selling hemp-derived THC drinks, In partnership with Marijuana Moment, meanwhile NuggMD has also been conducting quarterly presidential approval tracking polls that record cannabis consumer sentiment about the Trump administration’s actions on the issue. The latest iteration published last month found that Trump has seen a massive swing in support for his administration’s marijuana policy actions from consumers since moving to federally reschedule medical cannabis—with nearly three out of four now having a favorable view The post Cannabis Consumers Are Way More Likely To Dine At Restaurants That Offer THC Drinks As An Alcohol Alternative, Poll Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

May possibly fairly recently up and running an important web log, the data one offer you on this web site contains given a hand to all of us substantially. Bless you designed for your current precious time & get the job done. 성인 PC방 처벌

Excellent article. Very interesting to read. I really love to read such a nice article. Thanks! keep rocking. toto macau If more people that write articles involved themselves with writing great content like you, more readers would be interested in their writings. I have learned too many things from your article. judi bola

Every Pennsylvania Democratic senator is joining together in support of a procedural move that aims to increase pressure on Republicans to allow a vote on legalizing marijuana in the state. Led by Sen. Sharif Street (D), the lawmakers filed what is known as a discharge resolution that seeks to bring a bipartisan cannabis legalization bill out of committee, where it is stuck, and onto the floor for a vote. The bill in question is sponsored by Street along with Sen. Dan Laughlin (R), who chairs the Senate Law & Justice Committee but hasn’t called the legislation up for consideration in the panel. The GOP chairman has instead focused on moving a separate bill to create a new Cannabis Control Board to regulate medical marijuana and hemp. That measure failed on the Senate floor earlier this month amid partisan fighting about the best way forward for cannabis in the state. “The people of Pennsylvania deserve a vote on adult-use cannabis,” Street said when introducing the discharge resolution on Monday. “Not next year, not after another study, not after another election. They deserve a vote now.” All 23 members of the Senate Democratic caucus are signed onto the resolution, he noted, though he pointed out that cannabis legalization itself “is no longer a Democratic issue or Republican issue, it is a Pennsylvania issue.” “Cannabis reform has bipartisan support and deserves a bipartisan vote,” he said. “Every one of our neighboring states has moved ahead. Pennsylvanians are crossing state lines every day to purchase legal cannabis in those states, and unfortunately, having to transport it illegally, supporting businesses and generating tax revenue in other places. Our residents spend the money, our neighboring states collect the revenue… Legalization would generate recurring revenue that could help us invest in our public schools, strengthen mass transit, support public community development, improve public safety and reduce structural deficits that challenge the commonwealth year after year. This is not a one-time windfall. It is an ongoing source of revenue that can help us meet our ongoing obligations.” “We believe this issue has been debated long enough,” Street said. “It is time for the Senate to do its job and allow the people’s elected representatives to vote.” Watch Street’s comments, starting around 39:08 into the video below: Discharge resolutions are placed on the Senate calendar but are not automatically brought up for consideration; that is within the discretion of majority leadership. If a resolution is brought up and supported by a majority vote, however, the legislation in question would then be brought out of committee. Republicans currently hold a 27-23 majority in the chamber. “I understand that this discharge resolution does not compel the committee to report the bill,” Street said on Monday. “I understand that it may not force a vote, but it does force a conversation.” “It asks a simple question: if a bipartisan bill has the support of every member of the Senate Democratic caucus, was introduced with a Republican prime sponsor, has the support of the governor, has the support of a majority of Pennsylvanians, and now has demonstrated bipartisan momentum in this chamber, why shouldn’t it at least receive an up or down vote?” “The Senate should not fear debate, we should not fear democracy and we should certainly not fear allowing our colleagues to vote on an issue that has been before this body for a decade,” he said. “The time has come.” The marijuana legalization bill that Street wants to advance, SB 120, would allow adults aged 21 and older to possess up to 30 grams of cannabis flower, 1,000 milligrams of THC in edible products and 5 grams of concentrate. It would also create a process to expunge prior marijuana-related criminal records. If enacted, there would be an 8 percent excise tax on cannabis sales, alongside the state’s regular sales tax of 6 percent. The legislative maneuvering around the bill comes as new poll shows that Pennsylvania voters overwhelmingly support marijuana legalization—and that the largest share put the blame on Republican lawmakers for the fact that the state has not yet enacted the reform. The survey, conducted by Public Policy Polling this month, found that three out of four voters favor legalizing recreational cannabis. When asked whether “adults over 21 should have places to purchase non-medical cannabis products that are legal, and strictly regulated,” 55 percent said they strongly agree and 20 percent somewhat agree. Only 16 percent strongly disagree and 7 percent somewhat disagree, with another 3 percent saying they are unsure. The poll also found that 40 respondents blamed GOP lawmakers for the lack of progress on cannabis, 12 percent blamed Democrats and 9 percent said the governor was to blame. Gov. Josh Shapiro (D) has repeatedly called on lawmakers to send him a marijuana legalization bill and for the last several years has included the reform in his budget requests to the legislature. Republican gubernatorial nominee Stacy Garrity, who is running against Shapiro, recently pledged to veto a marijuana legalization bill if lawmakers ever sent one to her desk—though she added that she doesn’t think the reform stands a chance of making it that far in the state. “I don’t support legalizing recreational marijuana,” she said. “Recreational marijuana will not end up in the budget. They’re never going to pass it…not as long as Senate Republicans are in control of the Senate.” Her running mate for lieutenant governor, Jason Richey, claimed that legalizing marijuana would be “catastrophic” for the state, arguing it would increase the size of the illegal market, undermine job creation and harm public health. In April, the Democrstic-controlled Pennsylvania House of Representatives passed budget legislation proposed by Shapiro that relies on revenue that would be generated from recreational marijuana sales, which has yet to be legalized in the state. The governor earlier this year, as he has in past years, included cannabis legalization and the resulting expected revenue in his budget request. The House last year passed a bill to legalize marijuana and put sales in state-owned dispensaries, but the Republican Senate majority has criticized that plan while also not advancing a cannabis legalization model of its own. The state’s Independent Fiscal Office (IFO) reported in February that legalizing cannabis in Pennsylvania would generate nearly half a billion dollars in annual revenue by 2028, an estimate that is a significantly larger cash windfall compared to projections from Shapiro’s own office. A spokesperson in the governor’s office said the Trump administration’s federal marijuana rescheduling move is an “important step” that “adds support” to his push to legalize cannabis. A GOP senator also said that federal reform will make it easier to legalize marijuana in the state. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, Laughlin is blaming the governor for the defeat this month of his bill to create a new Cannabis Control Board (CCB) to oversee the state’s medical marijuana program and intoxicating hemp products and that could also one day oversee recreational cannabis if it is legalized. Most GOP senators in the Republican-controlled chamber voted for the legislation from Laughlin, and all but two Democrats opposed it—with even some lawmakers who signed onto the measure as cosponsors ultimately voting against it. The governor “obviously weighed in on the Democratic side of the aisle and asked for a ‘no’ vote over there, successfully,” Laughlin said after the vote. “I knew it was a risk putting it up for a vote, because there were some discussions going back and forth… I had a little bit of a heads-up, but we chose to roll forward.” The governor’s office confirmed in a statement that he opposes the bill as drafted. “The Shapiro Administration remains supportive of comprehensive cannabis regulation, which would enable a competitive, revenue-generating adult-use market, protect patient access to the current Medical Marijuana Program and rein in hemp-based intoxicant products that are currently unregulated,” Rosie Lapowsky, a spokesperson for the governor, said. “Senate Bill 49 does not substantively advance those goals.” The now-defeated measure would transfer regulatory authority for the state’s existing medical cannabis program from the Department of Health to a new seven-member CCB. The body would oversee cannabis permits, enforcement, seed-to-sale tracking, advertising, labeling, testing and other aspects of the legal industry. Moments after the bill’s defeat on the Senate floor, the chamber adopted a motion to reconsider—but it’s not yet clear when or if the legislation will get another vote. Laughlin’s legislation would also significantly restrict most hemp THC products, aligning the state with a new federal policy that is set to take effect later this year recriminalizing preparations with total THC content of more than 0.3 percent on a dry-weight basis or more than 0.4 milligrams of THC per container. The action on the cannabis regulatory bill, SB 49, came shortly after the House of Representatives passed a bill to allow terminally ill patients to use medical cannabis in hospitals and other healthcare facilities. Photo courtesy of Mike Latimer. The post Pennsylvania Democratic Senators Put Pressure On GOP To Allow A Vote On Legalizing Marijuana appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I actually came out on your site when concentrating on just simply marginally submits. Awesome technique for upcoming, I'll be book-marking right away stop a person's entire rises. 성인 PC방 허가

People with chronic lower back pain who don’t respond to traditional therapies such as opioids experience “large, sustained, and statistically robust improvements” when they switch to inhaled cannabis, according to a new study. Researchers at Rabin Medical Center in Israel looked at longitudinal data from 241 patients with treatment-resistant lower back pain from 2020 to 2025. Not only did cannabis “markedly and durably” improve pain symptoms, but that was accompanied by “near-total displacement of opioids, NSAIDs, antidepressants and gabapentinoids,” the study, published in the journal Biomedicines, said. The authors said they chose to research the efficacy of inhaled or vaporized marijuana “because of its rapid onset, on-demand titratability, and patient preference.” The THC content in the cannabis used in the study ranged from 4-22 percent, while CBD concentration ranged from 2-22 percent. “Inhaled cannabis was associated with large, sustained, and statistically robust improvements in pain, disability, and pain interference, accompanied by near-total displacement of opioids, NSAIDs, antidepressants, and gabapentinoids.” “The within-patient benefit-risk profile…supports consideration of cannabis as a potentially clinically meaningful, opioid-sparing option in patients who have failed multimodal conventional therapy, pending confirmation in randomized comparative trials,” the study concluded. Researchers stressed that, while promising, the study should be followed up with “randomized comparative trials of inhaled cannabis versus continued multimodal therapy” to ensure that “causal claims can be made.” “In their absence, and pending such confirmation, these data support consideration of inhaled cannabis as a potentially clinically meaningful, opioid-sparing option for patients who have failed conventional multimodal therapy,” they said. “Concomitant opioid use fell from 100% at baseline to 4.6% at Year 5 (within-patient absolute risk reduction 95.4%).” This is far from the only study supporting the efficacy of marijuana in the treatment of pain—nor is it the first to suggest cannabis can serve as a substitute for conventional therapies such as opioids. In April, for example, a study found that using medical marijuana appears to help people reduce the use of other medications, including opioids, sleeping aids and antidepressants. They also experience far fewer negative side effects after switching to cannabis from prescription drugs, the study involving more than 3,500 patients determined. About one in three Americans who use CBD say they take it as an alternative or supplement to at least one medication—particularly painkillers—according to a federally funded study published in February. Similarly, another recent federally funded study, published by the American Medical Association (AMA), added more evidence that marijuana can serve as an effective substitute for opioids in chronic pain treatment. Other AMA-published research has found that legalizing marijuana for medical or recreational purposes is “significantly associated with reduced opioid use among patients diagnosed with cancer.” A separate paper published last year similarly found that medical marijuana legalization is “associated with significant reductions in opioid prescribing.” In August, meanwhile, Australian researchers published a study showing that marijuana can serve as an effective substitute for opioids in pain management treatment. Another study published last year in the journal Drug and Alcohol Review found that, among drug users who experience chronic pain, daily cannabis use was linked to a higher likelihood of quitting the use of opioids—especially among men. Other research also found that legalizing medical cannabis appeared to significantly reduce monetary payments from opioid manufacturers to doctors who specialize in pain, with authors finding “evidence that this decrease is due to medical marijuana becoming available as a substitute” for prescription painkillers. Further research also showed a decline in fatal opioid overdoses in jurisdictions where marijuana was legalized for adults. That study found a “consistent negative relationship” between legalization and fatal overdoses, with more significant effects in states that legalized cannabis earlier in the opioid crisis. Authors estimated that recreational marijuana legalization “is associated with a decrease of approximately 3.5 deaths per 100,000 individuals.” “Our findings suggest that broadening recreational marijuana access could help address the opioid epidemic,” that report said. “Previous research largely indicates that marijuana (primarily for medical use) can reduce opioid prescriptions, and we find it may also successfully reduce overdose deaths.” Another recently published report into prescription opioid use in Utah following the state’s legalization of medical marijuana found that the availability of legal cannabis both reduced opioid use by patients with chronic pain and helped drive down prescription overdose deaths statewide. Overall, results of the study indicated that “cannabis has a substantial role to play in pain management and the reduction of opioid use,” it said. The post Marijuana Leads To ‘Robust Improvements’ In Lower Back Pain And ‘Near-Total’ Cessation Of Opioids, Study Finds appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

i never know the use of adobe shadow until i saw this post. thank you for this! this is very helpful. toto macau I’ve been surfing online more than 5 hours today, yet I never found any interesting article like yours without a doubt. It’s pretty worth enough for me. Thanks... toto slot

An individual's song is certainly impressive. You will have certain rather qualified musicians and artists. That i like everyone one of the best for results. 성피연합

Basically When i understand the item this morning although I did many thought processes concerning this and today I need to to learn to read the item all over again mainly because it is quite well written. 성인 PC방 벌금

That is thus gorgeous and also imaginative. I recently really like the particular shades and also anyone who receives that inside the email will probably be beaming. taruhan bola World of warcraft! What precisely tabs opener the place has long been in my situation. Considerably preferred, bookmarked as their favorite, That i can’t look forward to even more! taruhan bola That is thus gorgeous and also imaginative. I recently really like the particular shades and also anyone who receives that inside the email will probably be beaming. live macau That is thus gorgeous and also imaginative. I recently really like the particular shades and also anyone who receives that inside the email will probably be beaming. result macau That is thus gorgeous and also imaginative. I recently really like the particular shades and also anyone who receives that inside the email will probably be beaming. situs toto That is thus gorgeous and also imaginative. I recently really like the particular shades and also anyone who receives that inside the email will probably be beaming. toto 4D That is thus gorgeous and also imaginative. I recently really like the particular shades and also anyone who receives that inside the email will probably be beaming. depo 5k That is thus gorgeous and also imaginative. I recently really like the particular shades and also anyone who receives that inside the email will probably be beaming. judi bola

Bipartisan lawmakers: Blocking rescheduling won’t work; Marijuana reformers rally outside DEA; SCOTUS on cannabis & gun rights; VA legalization Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Lawyers for the Drug Enforcement Administration and a Food and Drug Administration official highlighted testimony on marijuana’s medical benefits and its relative safety compared to other substances such as alcohol and opioids on the first day of a hearing on cannabis rescheduling. Bipartisan lawmakers told Marijuana Moment that they don’t think efforts in Congress to block the Trump administration’s cannabis rescheduling proposal will succeed as a Drug Enforcement Administration hearing on the reform begins. Rep. Byron Donalds (R-FL), who is running for Florida governor, however, said “we’re not going to do recreational” marijuana legalization in the state. Marijuana reform activists held a press conference outside the Drug Enforcement Administration’s hearing on cannabis rescheduling to highlight how supporters are being “shut out” of the process. Meanwhile, DEA is sticking to its refusal to livestream the proceedings despite requests for public access from Marijuana Moment, a congressman and others—yet it is maintaining that it has a “commitment to transparency.” The Supreme Court is applying its ruling on marijuana consumers’ gun rights to other pending cases by rejecting the government’s previously filed appeals of lower court decisions and sending a case from a cannabis user back to a lower court “for further consideration in light of United States v. Hemani.” The Virginia Senate and House of Delegates accepted Gov. Abigail Spanberger’s (D) amendments to a budget bill containing provisions to legalize recreational marijuana sales—meaning that the legislation has now been formally enacted into law without requiring any additional action from the governor. National Cannabis Industry Association Policy Chair Michael Cooper authored a new Marijuana Moment op-ed calling out Republican lawmakers who want to maintain the 280E tax penalty on cannabis businesses even after rescheduling. “These Republican members of Congress appear to be hoping to undermine President Donald Trump’s position…by preserving punitive tax treatment for licensed cannabis businesses, regardless of their classification under federal law.” An Idaho campaign working to qualify a medical cannabis legalization initiative for the November ballot has hit setbacks as a judge ruled signatures in one county were turned in late—while others are at risk of being thrown out due to the possibility they may have been collected by out-of-state petitioners. / FEDERAL The head of the National Guard Counterdrug Program spoke about how “what once focused primarily on local and state marijuana eradication missions has expanded into disrupting activities and dismantling drug trafficking and transnational criminal organizations.” Rep. Jim Baird (R-IN) tweeted, “I am also grateful that the Trump Administration is calling for fair treatment of our hemp farmers. The hemp provision included in the Continuing Resolution and Appropriations bills passed in November 2025 disrupted planting decisions that had already been made. I appreciate the Trump Administration’s advocacy for greater predictability for farmers in Indiana and across the country.” / STATES Rhode Island Gov. Dan McKee’s (D) reelection campaign is facing a complaint over allegedly improper activity related to fundraising from the cannabis industry. Texas regulators adopted changes to rules on medical cannabis registration. Maryland regulators sent a notice about Drug Enforcement Administration inspections at marijuana dispensaries. New York regulators are accepting abstracts for a medical cannabis symposium in November. The Washington State Liquor and Cannabis Board will meet on Wednesday. The Michigan Cannabis Regulatory Agency will hold a public meeting on Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL Several Mexican elected officials are reportedly offering themselves as informants to U.S. authorities investigating drug cartels. Irish government officials are reportedly not keen to adopt a legislative committee’s recommendation to decriminalize drugs. / SCIENCE & HEALTH A study found that cannabis extracellular vesicle-like nanoparticles “offer a promising natural approach to protect the skin from UVB-induced damage, supporting their potential as bioactive candidates for future skincare or cosmeceutical applications for preventing photoaging and inflammation.” A study of mice found that “cannabidiol reduces atypical absence seizures and epileptic spasms.” / ADVOCACY, OPINION & ANALYSIS The International Cannabis Bar Association joined the call for the Drug Enforcement Administration to livestream an ongoing marijuana rescheduling hearing. / BUSINESS TerrAscend Corp. shareholders are being asked to approve a proposal to consolidate shares in preparation for uplisting to a major U.S. exchange. iAnthus Capital Holdings, Inc. shareholders elected board of directors members. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post DEA highlights cannabis’s medical benefits & relative safety in rescheduling hearing (Newsletter: June 30, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Online is definitely bogged all the way down by using bogus blogs and forums devoid of serious principles although the posting appeared to be brilliant plus definitely worth a learn. Thanks a ton to get spreading the following with me. 성인 PC방 매매

She was the kind of dangerous that makes your heart race and your body ache for more. My Chandni Chowk Escort was bold, beautiful, and breathtakingly erotic. We explored desires I never knew existed. Escort Service in Chandni Chowk brings a whole new level of passion that leaves you completely addicted and craving more.

Discover why Escort Hazrat Nizamuddin are the best choice for erotic companionship. Our escorts in Hazrat Nizamuddin are a perfect blend of beauty and expertise. The Hazrat Nizamuddin escort service ensures your privacy is protected. This premier Hazrat Nizamuddin escort service delivers an exceptional experience. Your perfect Hazrat Nizamuddin escort is waiting to satisfy you completely.हेलो

I am happy to find this post very useful for me, as it contains lot of information. I always prefer to read the quality content and this thing I found in you post. Thanks for sharing. 성인 피시방

Searching for a beautiful Janakpuri Escort to accompany you during your stay or evening out? We provide an elite platform where you can connect with charming professionals who are skilled at ensuring every moment is delightful and stress-free. Our focus is entirely on your comfort and happiness, providing a high-class service that stands out from the rest. Take the next step toward a truly rewarding encounter by reaching out to our friendly team for booking details.

Very nice article, I enjoyed reading your post, very nice share, I want to twit this to my followers. Thanks!. 성인 피시방 매매

Our stunning and lovely escorts in Govindpuri are ready to join you. They look forward to meeting you and discussing your services with you. Each Escort Service in Govindpuri arrives with complete privacy guaranteed. There is no need for you to stress over anything. We aim to provide you with a secure experience in which all your details remain private.